Literature DB >> 11893556

Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells.

Pin-Lan Li1, David X Zhang, Zhi-Dong Ge, William B Campbell.   

Abstract

We recently reported that cADP-ribose (cADPR) and ADP-ribose (ADPR) play an important role in the regulation of the Ca(2+)-activated K(+) (K(Ca)) channel activity in coronary arterial smooth muscle cells (CASMCs). The present study determined whether these novel signaling nucleotides participate in 11,12-epoxyeicosatrienoic acid (11,12-EET)-induced activation of the K(Ca) channels in CASMCs. HPLC analysis has shown that 11,12-EET increased the production of ADPR but not the formation of cADPR. The increase in ADPR production was due to activation of NAD glycohydrolase as measured by a conversion rate of NAD into ADPR. The maximal conversion rate of NAD into ADPR in coronary homogenate was increased from 2.5 +/- 0.2 to 3.4 +/- 0.3 nmol*(-1) *mg protein(-1) by 11,12-EET. The regioisomers of 8,9-EET, 11,12-EET, and 14,15-EET also significantly increased ADPR production from NAD. Western blot analysis and immunoprecipitation demonstrated the presence of NAD glycohydrolase, which mediated 11,12-EET-activated production of ADPR. In cell-attached patches, 11,12-EET (100 nM) increases K(Ca) channel activity by 5.6-fold. The NAD glycohydrolase inhibitor cibacron blue 3GA (3GA, 100 microM) significantly attenuated 11,12-EET-induced increase in the K(Ca) channel activity in CASMCs. However, 3GA had no effect on the K(Ca) channels activity in inside-out patches. 11,12-EET produced a concentration-dependent relaxation of precontracted coronary arteries. This 11,12-EET-induced vasodilation was substantially attenuated by 3GA (30 microM) with maximal inhibition of 57%. These results indicate that 11,12-EET stimulates the production of ADPR and that intracellular ADPR is an important signaling molecule mediating 11,12-EET-induced activation of the K(Ca) channels in CASMCs and consequently results in vasodilation of coronary artery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893556     DOI: 10.1152/ajpheart.00736.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume.

Authors:  Chi Young Shim; Sajeevani Kim; Scott Chadderdon; Melinda Wu; Yue Qi; Aris Xie; Nabil J Alkayed; Brian P Davidson; Jonathan R Lindner
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-21       Impact factor: 4.310

Review 2.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 3.  Regulation of TRPM2 channels in neutrophil granulocytes by ADP-ribose: a promising pharmacological target.

Authors:  Inka Heiner; Natalia Radukina; Jörg Eisfeld; Frank Kühn; Andreas Lückhoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

4.  H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation.

Authors:  David X Zhang; Lena Borbouse; Debebe Gebremedhin; Suelhem A Mendoza; Natalya S Zinkevich; Rongshan Li; David D Gutterman
Journal:  Circ Res       Date:  2011-12-08       Impact factor: 17.367

Review 5.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 6.  Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.

Authors:  J D Imig
Journal:  Adv Pharmacol       Date:  2016-05-05

Review 7.  Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.

Authors:  John D Imig
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-01-17       Impact factor: 3.072

8.  Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.

Authors:  Pin-Lan Li; Yang Zhang; Justine M Abais; Joseph K Ritter; Fan Zhang
Journal:  Messenger (Los Angel)       Date:  2013-06-01

Review 9.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.

Authors:  John D Imig; Christiana Dimitropoulou; D Sudarshan Reddy; Richard E White; John R Falck
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.